The page is the record's research on the issuer — no analyst, no rating, no view.

IXICO PLC (IXI) — research page

UK · uk-cm-kg/AIM/IXI · as of 2026-11-06

Identity and listing

The issuer is IXICO PLC, listed on AIM under ticker IXI, with ISIN GB00BFXR4C20 and LEI 2138005M1F59O6HWSA97. Its security type is Corporate, its segment is ASQ1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.

fieldvaluesource · read date
nameIXICO PLCsource · 2026-11-06
exchangeAIMsource · 2026-11-06
tickerIXIsource · 2026-11-06
ISINGB00BFXR4C20source · 2026-11-06
LEI2138005M1F59O6HWSA97source · 2026-11-09
security typeCorporatesource · 2026-11-06
segmentASQ1source · 2026-11-06
sectorPharmaceuticals and Biotechnology [201030]source · 2026-11-06
jurisdictionEngland and Wales (Companies House jurisdiction field)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 49 filings in the twelve months to 2026-11-06, across 37 filing days. The median gap between filing days is 5.5 days. The latest filing is dated 2026-11-02, is a regulatory announcement, and falls 4 days before the record date. On AIM the median cadence gap is 7.0 days, the median filings count is 33.5 and the median latency is 4 days across 594 issuers. In the sector the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days across 51 issuers. The issuer's filings are 49, above the AIM median of 33.5 and above the sector median of 42.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer495.54
exchange median: AIM (594 issuers)33.574
sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers)4264
datetypecategoryfiling
2026-11-02regulatory_announcement£2.7m clinical phase 3 contract win
2026-10-29regulatory_announcementIXICO Presents New Huntington's Disease Research
2026-10-22regulatory_announcementAlzheimer's contract wins
2026-10-20financial_statementTrading Update
2026-10-07ch_confirmation_statementconfirmation statement with no updates — 2026-10-01

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Moore Kingston Smith LLP. Its location is not on the record. Auditor changes are not on the record.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists for this register yet. The halt flag shows listed, not halted.

Orderability

For elective professional client the outcome is signal ACM-200, determinable. For eligible counterparty the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
elective professional clientACM-200
eligible counterpartyACM-200

rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The field has not been read, so the research houses named on the issuer's investor-relations page are not on the record.

Open research

The field has not been read, so openly published research notes are not on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store for this issuer but are not served as of a date, and the as-of door answers not_sealed. The market's vintage is not sealed, so the earliest sealed date of the market is not on the record. The live record began on 2026-09-11.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
10.2
https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/IXI (identity.isin)
10.3
https://find-and-update.company-information.service.gov.uk/company/03131723 (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://www.londonstockexchange.com/stock/IXI/ixico-plc/company-page (identity.sector)
10.6
https://mcp.uk-cm-kg.ai/events/AIM/IXI (the disclosure lines)
10.7
https://marketsecurities.fca.org.uk/officiallist (the halt flag)
10.8
https://ixico.com/assets/Company-documents/IXICO-Annual-Report-2024.pdf (the auditor)
10.9
https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
10.10
https://mcp.uk-cm-kg.ai/record/AIM/IXI (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"GB00BFXR4C20"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:4a2d217ec2c06572.